Dealing with the positive publication bias: Why you should really publish your negative results

A Mlinarić, M Horvat, V Šupak Smolčić - Biochemia medica, 2017 - hrcak.srce.hr
Sažetak Studies with positive results are greatly more represented in literature than studies
with negative results, producing so-called publication bias. This review aims to discuss …

[HTML][HTML] Sample size considerations for fine-tuning large language models for named entity recognition tasks: methodological study

ZP Majdik, SS Graham, JC Shiva Edward… - Jmir ai, 2024 - ai.jmir.org
Background Large language models (LLMs) have the potential to support promising new
applications in health informatics. However, practical data on sample size considerations for …

Early discontinuation, results reporting, and publication of pediatric clinical trials

R Brewster, M Wong, CJ Magnani, H Gunningham… - …, 2022 - publications.aap.org
METHODS Cross-sectional analysis of clinical trials enrolling participants< 18 years old
registered at ClinicalTrials. gov from October 2007 to March 2020. Multivariable logistic …

Evidence for stratified conflicts of interest policies in research contexts: a methodological review

SS Graham, MS Karnes, JT Jensen, N Sharma… - BMJ open, 2022 - bmjopen.bmj.com
Objectives The purpose of this study was to conduct a methodological review of research on
the effects of conflicts of interest (COIs) in research contexts. Design Methodological review …

Noncompletion and nonpublication of trials studying rare diseases: a cross-sectional analysis

CA Rees, N Pica, MC Monuteaux, FT Bourgeois - PLoS medicine, 2019 - journals.plos.org
Background Rare diseases affect as many as 60 million people in the United States and
Europe. However, most rare diseases lack effective therapies and are in critical need of …

Ensuring the scientific value and feasibility of clinical trials: A qualitative interview study

W Morrell, L Gelinas, D Zarin, BE Bierer - AJOB Empirical Bioethics, 2023 - Taylor & Francis
Background Ethical and scientific principles require that clinical trials address an important
question and have the resources needed to complete the study. However, there are no clear …

Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results

MS Khan, I Shahid, N Asad, SJ Greene… - ESC heart …, 2021 - Wiley Online Library
Aims Discontinuation or non‐publication of trials may hinder scientific progress and violates
the commitment made to research participants. We sought to identify the prevalence of …

Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0–8 years old

M Cipolli, G Tridello, A Micheletto, S Perobelli… - BMJ open, 2019 - bmjopen.bmj.com
Objectives Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disorder.
Its predominant manifestations include exocrine pancreatic insufficiency, bone marrow …

Rates of discontinuation and non-publication of upper and lower extremity fracture clinical trials

S Shepard, JM Anderson, B Heigle… - Journal of Orthopaedic …, 2023 - Springer
Purpose To our knowledge, no study has quantified the rate of discontinuation and
nonpublication of randomized controlled trials (RCTs) regarding upper and lower extremity …

Discontinuation and nonpublication of clinical trials in orthopaedic oncology

G Singh, A Wague, A Arora, V Rao, D Ward… - Journal of Orthopaedic …, 2024 - Springer
Background Despite the pivotal role of clinical trials in advancing orthopaedic oncology
knowledge and treatment strategies, the persistent issues of trial discontinuation and …